H istiocytic necrotizing lymphadenitis (or Kikuchi-Fujimoto disease) is a self-healing disease of unknown etiology, which frequently affects young adult females and typically presents as cervical lymphadenopathy. [1] [2] [3] Although this disease has a worldwide distribution, it is the most prevalent in Asia, including Japan. Clinically, Kikuchi-Fujimoto disease can be difficult to differentiate from several types of lymphomas. 4, 5 Histologically, Kikuchi-Fujimoto disease is characterized by localized necrosis and infiltration of large immunoblasts and plasmacytoid monocytes. 6 In case of diffuse infiltration of large immunoblasts, immunohistochemical staining including CD30 can sometimes be used to distinguish several types of lymphomas including Hodgkin lymphoma (HL) and peripheral T-cell lymphoma such as anaplastic large cell lymphoma (ALCL). In addition, systemic lupus erythematosus (SLE) mimics Kikuchi-Fujimoto disease histologically at the time of presentation. Thus far, however, no study has documented the extent or distribution pattern of CD30-positive cells in Kikuchi-Fujimoto disease. According to our observation, CD30-positive cells in Kikuchi-Fujimoto disease showed a characteristic distribution pattern around necrotic areas. Here we further investigated this initial finding by evaluating more KikuchiFujimoto disease cases using clinicopathologic analysis. Furthermore, we compared our histologic evaluation with SLE and reactive lymphoid hyperplasia (RLH) cases.
MATERIALS AND METHODS

Case Selection
Thirty patients with Kikuchi-Fujimoto disease were selected from the consultation files of the Department of Pathology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences (October 2003 to September 2015). In addition, 6 SLE and 10 RLH cases were selected as the control group. This study was conducted with the approval of the Institutional Review Board of Okayama University, Okayama, Japan (approval number 493). All study procedures were conducted in accordance with the guidelines of the Declaration of Helsinki.
Histology, Immunohistochemistry, and Immunofluorescence Study
Tissue samples were fixed in 10% formalin and embedded in paraffin for further analyses. The primary antibodies and probes used for immunohistochemical and immunofluorescent studies are summarized in Table 1 . Immunohistochemical staining was performed with an automated stainer (Roche Diagnostics Medical System, Tucson, AZ) or an automated Bond-max stainer (Leica Biosystems, Melbourne, Vic., Australia), as described previously. 7 For double immunofluorescence staining, antimouse Alexa flour 555 (1:400; Invitrogen Co., Waltham, MA) and anti-rabbit Alexa flour 488 (1:400; Invitrogen) were used as secondary antibodies. This study was performed according to standard procedures, as described previously. 8 In situ hybridization of EBER-1 was performed using a Bond-max stainer (Leica Biosystems).
CD30-positive cells and CD123-positive cells were counted in 3 areas of high-power fields (3HPFs) with abundant CD30-positive cells or CD123-positive cells and the mean was calculated. For the 30 cases of KikuchiFujimoto disease, CD30-positive cells around both necrotic areas and non-necrotic areas were counted.
Statistical Analysis
The w 2 test, t test, or Mann-Whitney U test was performed to analyze all data using the SPSS software version 14.0 (SPSS Inc., Chicago, IL). P-values <0.05 were considered significant.
RESULTS
Clinical Findings in Kikuchi-Fujimoto Disease Cases
The clinical features of the 30 Kikuchi-Fujimoto disease cases are summarized in Table 2 . The patient age was 12 to 40 years (median, 27.5 y), and there were 11 men and 19 women. The site most frequently involved was the cervical lymph node (28 patients), followed by axillary (5 patients), inguinal (4 patients), supraclavicular (3 patients), and submandibular (1 patient) lymph nodes. In addition, 1 patient presented with parotid and submandibular gland swelling and 1 presented with bilateral tonsillar swelling.
Furthermore, 18 patients presented with pain of the affected lymph nodes and 15 presented with fever. The following abnormal laboratory data were observed: leukopenia (12 patients), anemia (5 patients), thrombocytopenia (3 patients), elevated serum AST and ALT levels (4 patient), elevated serum LDH levels (14 patients; median 224 IU/L, range, 129 to 494), and elevated serum soluble interleukin-2 receptor (12 patients; median 692.5 U/mL, range, 242 to 1290).
Histologic and Immunohistochemical Findings of Kikuchi-Fujimoto Disease and SLE Cases
Typical histologic patterns such as localized necrosis (Fig. 1A) , apoptotic bodies, degenerated nuclei, and crescentic histiocytes (Fig. 1B) were observed in all Kikuchi-Fujimoto disease patients' samples.
Infiltration of many large immunoblasts and plasmacytoid monocytes (Fig. 1C) were seen around necrotic areas. In non-necrotic areas, the number of immunoblasts was much less than that around necrotic areas (Fig. 1D) . Immunohistochemically, plasmacytoid monocytes were positive for myeloperoxidase and lysozyme (Fig. 1E, F ). CD3-positive T cells were much more predominant than CD20-positive B cells around necrotic areas (Fig. 1G, H) .
On the contrary, localized necrosis as well as Kikuchi-Fujimoto disease was seen in 5 of 6 SLE cases. One case presented massive necrosis area and the other 4 cases showed focal necrosis with follicular hyperplasia. Although large immunoblasts were seen in SLE samples, plasmacytoid monocytes were fewer than Kikuchi-Fujimoto disease.
Number, Pattern, and Phenotypes of CD30-positive Cells CD30-positive large cells were observed in non-necrotic, with most located around necrotic areas ( Fig. 2A-D) . The number of CD30-positive cells counted in each case is summarized in Table 2 . Around necrotic areas, the number of CD30-positive cells was 10 to 138.3 (mean, 40.1) cells/HPF, whereas it was 2.7 to 21.3 (mean, 9.3) cells/HPF in non-necrotic areas. Thus, a significantly greater infiltration of CD30-positive cells was observed around necrotic areas than non-necrotic areas (P < 0.001; Fig. 3A) .
To examine whether this phenomenon was characteristic of Kikuchi-Fujimoto disease, we compared our immunohistochemical findings with those of SLE and RLH. In SLE and RLH cases, CD30-positive cell counts (Table 3 ). Both the diseases showed significantly lesser CD30-positive cell infiltration than that in Kikuchi-Fujimoto disease (both P < 0.05; Fig. 3B ). Next, we investigated the phenotypes of the CD30-positive cell population. Kikuchi-Fujimoto disease and SLE showed infiltration of CD123-positive cells in necrotic areas (Fig. 4A, B and Tables 2 and 3 ). In RLH cases, CD123-positive cells were mainly seen in interfollicular areas (Fig. 4C and Table 3 ). In double immunohistochemical staining, CD30-positive cells were negative for CD123 (Fig. 4D) . The number of infiltrating CD123-positive cells was significantly larger in KikuchiFujimoto disease than control cases (Fig. 4E) . Furthermore, all cases of Kikuchi-Fujimoto disease were negative for EBER-1. Double immunofluorescence staining showed that CD30-positive cells were CD3-positive T cells, but not CD20-positive B cells (Fig. 5A) . They also expressed CD8 and cytotoxic molecules such as TIA-1 and Granzyme B. Thus, our results indicated that CD30-positive cells were CD8-positive cytotoxic T cells (Fig. 5B) .
Clinicopathologic Features of CD30-positive Cells Abundant Cases
Among Kikuchi-Fujimoto disease cases, clinicopathologic features were compared according to the abundance of CD30-positive cells. We divided our cases into an abundant group (Z22 cells/HPF around necrotic area) and a scarce group (< 22 cells/HPF). The abundant group frequently included females (16/20 cases), was afebrile (12/20 cases), nonanemic (16/19 cases), and had normal C-reactive protein levels (8/16 cases; Table 4 ).
DISCUSSION
The diagnosis of Kikuchi-Fujimoto disease is sometimes difficult when large immunoblasts are a prominent histologic feature of the case. In this study, we showed a greater infiltration of CD30-positive large immunoblasts concentrated around necrotic areas compared with non-necrotic areas. We found that this phenomenon was more frequently observed in Kikuchi-Fujimoto disease than in the controls. Because SLE sometimes exhibits similar histology to Kikuchi-Fujimoto disease, the distribution pattern of CD30-positive cells may be helpful for differential diagnosis. Moreover, all SLE cases showed CD30-positive cells proliferation <20 cells/HPF and the number of infiltrating CD30-positive or CD123-positive cells was significantly larger in Kikuchi-Fujimoto disease than in SLE. From our present results, CD30 and CD123 would be more reliable marker for distinguishing Kikuchi-Fujimoto disease from SLE.
Unexpectedly, in cases with abundant CD30-positive cells, patients predominantly presented with only mild symptoms and normal laboratory data. Ohshima et al 9 reported that the majority of proliferating and apoptotic cells were CD8-positive T cells, but rarely CD4 positive. 10 In this study, CD30-positive cells were mostly CD8 positive (Fig. 5B) . It is considered that the CD8-positive cytotoxic T cells attack CD4-positive T cells and undergo this cell proliferation activity. 13 In contrast, CD30 stimulation can suppress or induce apoptosis in ALCL. [15] [16] [17] In HL, CD30 stimulation activates NF-kB through tumor necrosis factor receptor-associated factor and IkB kinase 18, 19 and NF-kB-induced expression of antiapoptotic proteins and cytokines promotes cell growth. 20, 21 We examined whether CD30-positive cells around necrotic areas also expressed NF-kB. Double immunofluorescent staining showed that CD30-positive cells also expressed p65 in their nucleus ( Supplementary Fig. 1A -C, Supplemental Digital Content 1, http://links.lww.com/AIMM/A122), suggesting that they can escape from apoptosis and actively proliferate. Because CD30-positive cells were observed to be CD8-positive cytotoxic T cells, these cells may induce apoptosis of surrounding cells and form localized necrotic foci.
In conclusion, concentration of CD30-positive and CD8-positive cytotoxic T cells around necrotic areas is a characteristic histologic feature differentiating it from SLE and RLH. Because the etiology of this disease remains unknown, further studies are necessary to clarify the pathogenesis of Kikuchi-Fujimoto disease. 
